GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Capital expenditures (TTM) | YoY | 5-year CAGR |
|---|---|---|
| $609M | +22.0% | −2.8% |
| Capital expenditures (TTM) | $609M |
|---|---|
| YoY | +22.0% |
| 5-year CAGR | −2.8% |
Capital expenditures
| Period | Capex | YoY |
|---|---|---|
| 2025 | $563M | +7.6% |
| 2024 | $523M | −10.6% |
| 2023 | $585M | −19.6% |
| 2022 | $728M | +25.7% |
| 2021 | $579M | −10.9% |
| 2020 | $650M | −21.2% |
| 2019 | $825M | −10.7% |
| 2018 | $924M | — |
| 2013 | $134M | — |